These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17667441)

  • 1. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
    von Falck C; Rosenthal H; Gratz KF; Galanski M
    Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
    Lin EC
    Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone involvement in patients with lymphoma: the role of FDG-PET/CT.
    Schaefer NG; Strobel K; Taverna C; Hany TF
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):60-7. PubMed ID: 17021808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: preliminary results of a prospective study.
    Paolini R; Rampin L; Rodella E; Ramazzina E; Banti E; Al-Nahhas A; Rubello D
    Nucl Med Rev Cent East Eur; 2007; 10(2):87-90. PubMed ID: 18228212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT.
    Sheehy N; Israel DA
    Clin Nucl Med; 2007 Oct; 32(10):820-1. PubMed ID: 17885370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of integrated PET-CT images in 2 lymphoma patients with skeletal localisations].
    Geerts MC; Quarles van Ufford HM; Kramer MH; van Waes PF; de Klerk JM
    Ned Tijdschr Geneeskd; 2006 Jan; 150(4):204-9. PubMed ID: 16471237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
    Guay C; Lépine M; Verreault J; Bénard F
    J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False positivity of FDG-PET/CT in a child with Hodgkin disease.
    Beker DB; Berrak SG; Canpolat C; Tugtepe H; Ones T; Tecimer T
    Pediatr Blood Cancer; 2008 Apr; 50(4):881-3. PubMed ID: 17417791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
    Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A
    J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?
    van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA
    J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.
    Bjurberg M; Gustavsson A; Ohlsson T; Brun E
    Acta Oncol; 2006; 45(6):743-9. PubMed ID: 16938818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease.
    Paes FM; Kalkanis DG; Sideras PA; Serafini AN
    Radiographics; 2010 Jan; 30(1):269-91. PubMed ID: 20083598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of FDG-PET in the definition of involved-field radiation therapy and management for pediatric Hodgkin's lymphoma.
    Robertson VL; Anderson CS; Keller FG; Halkar R; Goodman M; Marcus RB; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):324-32. PubMed ID: 20646867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
    Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
    J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma.
    Riad R; Omar W; Sidhom I; Zamzam M; Zaky I; Hafez M; Abdel-Dayem HM
    Nucl Med Commun; 2010 Mar; 31(3):232-8. PubMed ID: 20032800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG uptake in liposclerosing myxofibrous tumor causes upstaging of Hodgkin lymphoma.
    Kim J; Chen W; Resnik C; Dilsizian V; Chen Q; Kimball AS
    Clin Nucl Med; 2015 Apr; 40(4):325-7. PubMed ID: 25290293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.